Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005266659> ?p ?o ?g. }
- W2005266659 endingPage "437" @default.
- W2005266659 startingPage "425" @default.
- W2005266659 abstract "In the search for an effective vaccine against the human immunodeficiency virus (HIV), novel ways to deliver viral antigens are being evaluated. One such approach is the use of nonreplicating viral vectors encoding HIV and/or SIV genes that are expressed after infection of host cells. Nonreplicating poliovirus vectors, termed replicons, that expressed HIV-1/HXB2 and SIVmac239 gag and various HIV-1 env genes from different clades were tested for immunogenicity and protective efficacy against intravenous challenge of pig-tailed macaques with SHIV-89.6P. To maximize both cellular and humoral immune responses, a prime-boost regimen was used. Initially, macaques were immunized four times over 35 weeks by either the intranasal and intrarectal or the intramuscular (im) route with mixtures of poliovirus replicons expressing HIV-1 gag and multiple env genes. Immunization with replicons alone induced both serum antibodies and lymphocyte proliferative responses. After boosting with purified Env protein, neutralizing antibodies to SHIV-89.6P were induced in four of five immunized animals. In a second experiment, four macaques were immunized im three times over 27 weeks with replicons expressing the SIVmac239 gag and HIV-1/HXB2 env genes. All immunized animals were then boosted twice with purified HIV-1-89.6 rgp140-Env and SIVmac239 p55-Gag proteins. Four control animals received only the two protein inoculations. Immunized and control animals were then challenged intravenously with the pathogenic SHIV-89.6P. After challenge the animals were monitored for virus isolation from peripheral blood mononuclear cells and plasma viremia and for changes in virus-specific antibody titers. Naïve pig-tailed macaques experienced rapid loss of CD4+ T cells and died between 38 and 62 weeks after infection. In contrast, macaques immunized with replicons and proteins rapidly cleared plasma virus and did not experience sustained loss of CD4+ lymphocytes. Furthermore, two of the four macaques that were immunized only with purified proteins maintained high viral burdens and lost greater than 95% of their CD4+ lymphocytes within 2 to 4 weeks after challenge. Thus, poliovirus replicons expressing HIV-1 and SIV antigens were immunogenic in pig-tailed macaques and appeared to enhance the protective effects observed after administration of purified proteins alone." @default.
- W2005266659 created "2016-06-24" @default.
- W2005266659 creator A5045818846 @default.
- W2005266659 creator A5055664540 @default.
- W2005266659 creator A5063968729 @default.
- W2005266659 creator A5077698491 @default.
- W2005266659 creator A5087106402 @default.
- W2005266659 creator A5087386559 @default.
- W2005266659 date "2003-10-01" @default.
- W2005266659 modified "2023-09-26" @default.
- W2005266659 title "Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease" @default.
- W2005266659 cites W1482036567 @default.
- W2005266659 cites W1528520360 @default.
- W2005266659 cites W1534881087 @default.
- W2005266659 cites W1549087352 @default.
- W2005266659 cites W1553814633 @default.
- W2005266659 cites W1594804329 @default.
- W2005266659 cites W1596667011 @default.
- W2005266659 cites W1602599521 @default.
- W2005266659 cites W1605208680 @default.
- W2005266659 cites W1761637098 @default.
- W2005266659 cites W1821374416 @default.
- W2005266659 cites W1829913979 @default.
- W2005266659 cites W1966516021 @default.
- W2005266659 cites W1969251048 @default.
- W2005266659 cites W1988835951 @default.
- W2005266659 cites W2002301242 @default.
- W2005266659 cites W2006150708 @default.
- W2005266659 cites W2011858497 @default.
- W2005266659 cites W2018062778 @default.
- W2005266659 cites W2023309406 @default.
- W2005266659 cites W2029167935 @default.
- W2005266659 cites W2034130780 @default.
- W2005266659 cites W2038665432 @default.
- W2005266659 cites W2039760424 @default.
- W2005266659 cites W2051108441 @default.
- W2005266659 cites W2056568415 @default.
- W2005266659 cites W2057961805 @default.
- W2005266659 cites W2059745951 @default.
- W2005266659 cites W2060830625 @default.
- W2005266659 cites W2065329551 @default.
- W2005266659 cites W2076423932 @default.
- W2005266659 cites W2077348914 @default.
- W2005266659 cites W2078528472 @default.
- W2005266659 cites W2083854857 @default.
- W2005266659 cites W2090352803 @default.
- W2005266659 cites W2093122125 @default.
- W2005266659 cites W2093694709 @default.
- W2005266659 cites W2094535061 @default.
- W2005266659 cites W2098547843 @default.
- W2005266659 cites W2101581475 @default.
- W2005266659 cites W2103765613 @default.
- W2005266659 cites W2108028766 @default.
- W2005266659 cites W2108688664 @default.
- W2005266659 cites W2110287237 @default.
- W2005266659 cites W2111759310 @default.
- W2005266659 cites W2112852315 @default.
- W2005266659 cites W2117638704 @default.
- W2005266659 cites W2117745315 @default.
- W2005266659 cites W2121849883 @default.
- W2005266659 cites W2124640603 @default.
- W2005266659 cites W2125377878 @default.
- W2005266659 cites W2129166390 @default.
- W2005266659 cites W2129907648 @default.
- W2005266659 cites W2131505205 @default.
- W2005266659 cites W2135953287 @default.
- W2005266659 cites W2139257243 @default.
- W2005266659 cites W2144535873 @default.
- W2005266659 cites W2144882745 @default.
- W2005266659 cites W2149791183 @default.
- W2005266659 cites W2152908456 @default.
- W2005266659 cites W2153028137 @default.
- W2005266659 cites W2153163225 @default.
- W2005266659 cites W2153511385 @default.
- W2005266659 cites W2155021907 @default.
- W2005266659 cites W2156411630 @default.
- W2005266659 cites W2162187516 @default.
- W2005266659 cites W2162650424 @default.
- W2005266659 cites W2166553362 @default.
- W2005266659 cites W2167102696 @default.
- W2005266659 cites W2170446942 @default.
- W2005266659 cites W4239432304 @default.
- W2005266659 doi "https://doi.org/10.1016/s0042-6822(03)00546-4" @default.
- W2005266659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14585346" @default.
- W2005266659 hasPublicationYear "2003" @default.
- W2005266659 type Work @default.
- W2005266659 sameAs 2005266659 @default.
- W2005266659 citedByCount "16" @default.
- W2005266659 countsByYear W20052666592013 @default.
- W2005266659 countsByYear W20052666592016 @default.
- W2005266659 crossrefType "journal-article" @default.
- W2005266659 hasAuthorship W2005266659A5045818846 @default.
- W2005266659 hasAuthorship W2005266659A5055664540 @default.
- W2005266659 hasAuthorship W2005266659A5063968729 @default.
- W2005266659 hasAuthorship W2005266659A5077698491 @default.
- W2005266659 hasAuthorship W2005266659A5087106402 @default.
- W2005266659 hasAuthorship W2005266659A5087386559 @default.
- W2005266659 hasConcept C104317684 @default.